Patents by Inventor Joan Geoghegan

Joan Geoghegan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of microbial infections
    Patent number: 11512118
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: November 29, 2022
    Assignee: THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Andrej Tarkowski
  • TREATMENT OF MICROBIAL INFECTIONS
    Publication number: 20170202943
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 20, 2017
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Andrej Tarkowski
  • Treatment of microbial infections
    Patent number: 9637525
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: May 2, 2017
    Assignee: THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Andrej Tarkowski
  • Method of prophlactically treating infection using a recombinant fibrinogen binding protein clumping factor A (ClfA) or fragment thereof
    Patent number: 9353160
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Grant
    Filed: July 16, 2010
    Date of Patent: May 31, 2016
    Assignees: GLAXOSMITHKLINE BIOLOGICALS S.A., THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Guy Dequesne, Andrej Tarkowski, Carlake Andersson
  • TREATMENT OF MICROBIAL INFECTIONS
    Publication number: 20150232518
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Application
    Filed: May 1, 2015
    Publication date: August 20, 2015
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Andrej Tarkowski
  • TREATMENT OF INFECTIONS
    Publication number: 20120244189
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Application
    Filed: July 16, 2010
    Publication date: September 27, 2012
    Applicants: THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF, GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Guy Dequesne, Andrej Tarkowski, Carlake Andersson
  • TREATMENT OF MICROBIAL INFECTIONS
    Publication number: 20110150918
    Abstract: The present invention is directed to improved microbial antigen vaccines, pharmaceutical compositions, immunogenic compositions and antibodies and their use in the treatment of microbial infections, particularly those of bacterial origin, including Staphylococcal origin. Ideally, the present invention is directed to a recombinant staphylococcal MSCRAMM or MSCRAMM-like proteins, or fragment thereof, with reduced binding to its host ligand, for use in therapy.
    Type: Application
    Filed: January 29, 2009
    Publication date: June 23, 2011
    Inventors: Timothy Foster, Judy Higgins, Elisabet Josefsson, Joan Geoghegan, Carlake Andersson